Lymphoma and rifampin.
D000328:Adult; D006801:Humans; D008223:Lymphoma / Q000139:chemically induced*; D008297:Male; D009303:Nasopharyngeal Neoplasms / Q000139:chemically induced*; D012293:Rifampin / Q000009:adverse effects* / Q000627:therapeutic use; D014399:Tuberculosis, Spinal / Q000188:drug therapy
D012293:Rifampin